SEC Form 4 · accession 0001272247-26-000004
ANI PHARMACEUTICALS INC · ANIP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Thomas Haughey
Director
Period of report
May 21, 2026
Accepted (ET)
Jun 10, 2026 · 9:06 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001023024
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 21, 2026 | A | 4,357 | $0.00 | A | 40,878 | D | |
| Common Stock | Jun 8, 2026 | S | 2,000 | $80.88 | D | 38,878 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents a restricted stock award that will vest in full on May 21, 2027.
- F2The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 9, 2026.